LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC
LVAC was delisted on the 10th of May, 2023.
39 hedge funds and large institutions have $86.6M invested in LAVA Medtech Acquisition Corp. Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
1,050% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 2
117% more funds holding
Funds holding: 18 → 39 (+21)
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
92% more capital invested
Capital invested by funds: $45.1M → $86.6M (+$41.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GL
Governors Lane
New York
|
+$4.86M |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$3.98M |
| 3 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
+$3.72M |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$3.47M |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$2.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCM
Oaktree Capital Management
Los Angeles,
California
|
-$2.5M |
| 2 |
FLC
Fifth Lane Capital
Austin,
Texas
|
-$986K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$784K |
| 4 |
SV
Starboard Value
New York
|
-$61K |
LVAC Hedge Fund Activity: Q1 2022 in Review
39 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) for Q1 2022, worth a combined $86.6M — up 92% from $45.1M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new LVAC positions and 2 closed out — a net gain of 21 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Governors Lane, opening a new position worth an estimated $4.86M. The largest seller was Oaktree Capital Management, exiting entirely with an estimated $2.5M sold.
- 39 institutional investors held LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) as of Q1 2022, up from 18 in Q4 2021.
- Funds reported $86.6M of LAVA Medtech Acquisition Corp. Class A Common Stock stock for Q1 2022, up 92% quarter-over-quarter.
- 23 funds opened new LAVA Medtech Acquisition Corp. Class A Common Stock positions in Q1 2022 and 2 closed out, a net change of +21 holders.
- The largest LAVA Medtech Acquisition Corp. Class A Common Stock buyer in Q1 2022 was Governors Lane, an estimated $4.86M added.
- The largest LAVA Medtech Acquisition Corp. Class A Common Stock seller in Q1 2022 was Oaktree Capital Management, an estimated $2.5M sold.
Based on aggregated 13F filings for Q1 2022.